Ana María
López González
Institute Catalá Oncología
Barcelona, EspañaPublications in collaboration with researchers from Institute Catalá Oncología (3)
2022
-
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study
Cancers, Vol. 14, Núm. 23
-
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA
Future Oncology, Vol. 18, Núm. 34, pp. 3791-3800
2020
-
Fatty acid intake and breast cancer in the Spanish multicase–control study on cancer (MCC-Spain)
European Journal of Nutrition, Vol. 59, Núm. 3, pp. 1171-1179